Senior insider sale
Chief Financial Officer at AMYLYX PHARMACEUTICALS, INC. — senior position signals high conviction
$89.1K
6.88K shares
What this filing means
FRATES JAMES M plans to sell 6.88K shares of AMYLYX PHARMACEUTICALS, INC. valued at approximately $89.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001193125-26-033638
Officer· Chief Financial Officer
Since Jan 2022
6.88K
Shares to sell
$89.1K
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
N/A
2/2/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/2/2026 | Vesting of Restricted Stock Units N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.33K
Market value
$37.0K
1/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.56K
Market value
$52.1K
2/2/2026
Total
Units
6.88K
Value
$89.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/6/2026 | 3.33K | $37.0K | — | Completed |
| Planned — Approximate Date | ||||
2/2/2026 | 3.56K | $52.1K | NASDAQ | Planned |
| Total | 6.88K | $89.1K | ||